Finanzen von Precipio Inc (PRPO)PRPOPrecipio Inc

Precipio Inc (PRPO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Third party payers, accounting for 47.7% of total sales, equivalent to $2.69M. Other significant revenue streams include Medicare and Other. Understanding this composition is critical for investors evaluating how PRPO navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Precipio Inc maintains a gross margin of 44.67%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -8.53%, while the net margin is -3.12%. These profitability ratios, combined with a Return on Equity (ROE) of -8.98%, provide a clear picture of how effectively PRPO converts its operational activities into shareholder value.

In the context of the broader market, PRPO competes directly with industry leaders such as RYOJ and MBAI. With a market capitalization of $33.91M, it holds a significant position in the sector. When comparing efficiency, PRPO's gross margin of 44.67% stands against RYOJ's 26.47% and MBAI's N/A. Such benchmarking helps identify whether Precipio Inc is trading at a premium or discount relative to its financial performance.

Precipio's revenue has shown a positive trend, with Q2 2026 revenue reaching $7 million, a 22% increase from the previous year. However, the company has reported net losses in recent quarters, including a loss of $1.4 million in Q1 2026, indicating ongoing financial challenges.